See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy

Publications for Leonardo Brandao

Updated daily

Back to Member List

#	PubMedId	Deleted	Publication
	41257208	0	Dai G, Liu B, Liang X, et al. Rivaroxaban in Chinese children with giant coronary artery aneurysms after Kawasaki disease. Res Pract Thromb Haemost. 2025 Oct 6;9(7):103211. doi: 10.1016/j.rpth.2025.103211. eCollection 2025 Oct.
	40980256	0	Avila L, Thomas S, Mancini A, et al. Skeletal muscle oxygenation and fluid content in upper extremity postthrombotic syndrome: a proof-of-concept study. Res Pract Thromb Haemost. 2025 Aug 16;9(6):103008. doi: 10.1016/j.rpth.2025.103008. eCollection 2025 Aug.
	40640900	0	Mokhtar G, Abdelbaky A, Adly A, et al. Egyptian pediatric guidelines for the management of childhood venous thromboembolism: the adapted methodology: a limited resource country perspective. Thromb J. 2025 Jul 10;23(1):74. doi: 10.1186/s12959-025-00758-0.
	40561511	0	Kawtharany H, Azzam M, Alkhader A, et al. Efficacy and Safety of Thrombolysis for Pediatric Venous Thromboembolism: A Systematic Review and Meta-analysis. Blood Adv. 2025 Jun 25:bloodadvances.2025017058. doi: 10.1182/bloodadvances.2025017058.
	40423983	0	Monagle P, Azzam M, Bercovitz R, et al. American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients. Blood Adv. 2025 May 27;9(10):2587-2636. doi: 10.1182/bloodadvances.2024015328.
	40379105	0	Al-Huniti AH, Malcolmson C, Langlois V, et al. Benefits of Anticoagulation Prophylaxis in Children Undergoing Kidney Transplant: Systematic Review and Meta-Analysis. J Thromb Haemost. 2025 May 14:S1538-7836(25)00322-8. doi: 10.1016/j.jtha.2025.04.032.
	40353824	0	Avila L, Di Ruggiero E, Vincelli J, et al. Global Survey on Practice Changes and Barriers to the Use of Direct Oral Anticoagulants in Children. Blood Adv. 2025 May 12:bloodadvances.2025016681. doi: 10.1182/bloodadvances.2025016681.
	40316285	0	Srichumpuang C, Kor-Anantakul P, Brandao LR, et al. Compound heterozygous congenital protein C deficiency: a challenging management with recurrent purpura fulminans treated with protein C concentrations. BMJ Case Rep. 2025 May 2;18(5):e263471. doi: 10.1136/bcr-2024-263471.
	39830972	0	Bastas D, Mancini A, Wong G, et al. Health literacy in pediatric thrombosis: a landscape analysis. Res Pract Thromb Haemost. 2024 Dec 9;9(1):102653. doi: 10.1016/j.rpth.2024.102653. eCollection 2025 Jan.
	39798923	0	Betensky M, Albisetti M, Biss T, et al. Systematic Analysis of the Design, Methodology and Patient Population Characteristics of the Pediatric Direct Oral Anticoagulant (DOAC) Trials of Venous Thromboembolism Treatment. J Thromb Haemost. 2025 Jan 9:S1538-7836(24)00790-6. doi: 10.1016/j.jtha.2024.12.035.
	39321425	0	Betensky M, Mosha M, Tarango C, et al. Outcomes in children with provoked venous thrombosis and antiphospholipid antibodies: findings from the Kids-DOTT trial. Blood Adv. 2024 Nov 26;8(22):5790-5795. doi: 10.1182/bloodadvances.2024014415.
	39086106	0	Mancini A, Wong G, Bastas D, et al. Reliability, usability, and efficiency of video versus print instructions to teach parents a procedural task: A cross-sectional study. Pediatr Blood Cancer. 2024 Oct;71(10):e31237. doi: 10.1002/pbc.31237. Epub 2024 Jul 31.
	38959353	0	Alexander PMA, Bembea MM, Cashen K, et al. Executive Summary: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE (PEACE) Consensus Conference. Pediatr Crit Care Med. 2024 Jul 1;25(7):643-675. doi: 10.1097/PCC.0000000000003480. Epub 2024 Jul 3.
	38484629	0	Bosch A, Brunsvig Jarvis K, Brandao LR, et al. The role of coagulation factors VIII, IX and XI in the prediction and mediation of recurrent thrombotic events in children with non-central venous catheter deep vein thrombosis. Thromb Res. 2024 Apr;236:228-235. doi: 10.1016/j.thromres.2024.03.009. Epub 2024 Mar 7.
	38348778	0	Albisetti M, Tartakovsky I, Halton J, et al. Dabigatran for Treatment and Secondary Prevention of Venous Thromboembolism in Pediatric Congenital Heart Disease. J Am Heart Assoc. 2024 Feb 20;13(4):e028957. doi: 10.1161/JAHA.122.028957. Epub 2024 Feb 13.
	38057072	0	Payne RM, Burns KM, Glatz AC, et al. Apixaban for Prevention of Thromboembolism in Pediatric Heart Disease. J Am Coll Cardiol. 2023 Dec 12;82(24):2296-2309. doi: 10.1016/j.jacc.2023.10.010.
	37063770	0	Bastas D, Brandao LR, Vincelli J, et al. Physical activity for children with deep vein thrombosis and pulmonary embolism on anticoagulation: a scoping review. Res Pract Thromb Haemost. 2023 Feb 27;7(2):100094. doi: 10.1016/j.rpth.2023.100094. eCollection 2023 Feb.
	36763520	0	Avila ML, Bentley RF, Bastas D, et al. Unraveling the pathophysiology of lower-limb postthrombotic syndrome in adolescents: a proof-of-concept study. Blood Adv. 2023 Jun 27;7(12):2784-2793. doi: 10.1182/bloodadvances.2022009599.
	36739234	0	Bastas D, Brandao LR, Allen DD, et al. Functional impact of pediatric postthrombotic syndrome. J Thromb Haemost. 2023 Apr;21(4):896-904. doi: 10.1016/j.jtha.2023.01.004. Epub 2023 Jan 10.
	36456034	0	Mandel-Shorer N, Sabapathy CA, Krishnan P, et al. Cerebral Sinovenous Thrombosis in Infants and Children: A Practical Approach to Management. Semin Pediatr Neurol. 2022 Dec;44:100993. doi: 10.1016/j.spen.2022.100993. Epub 2022 Sep 10.
	36150047	0	Brandao LR, Tartakovsky I, Albisetti M, et al. Dabigatran in the treatment and secondary prophylaxis of venous thromboembolism in children with thrombophilia. Blood Adv. 2022 Nov 22;6(22):5908-5923. doi: 10.1182/bloodadvances.2021005681.
	36006613	0	Palumbo JS, Lensing AWA, Brandao LR, et al. Anticoagulation in pediatric cancer-associated venous thromboembolism: a subgroup analysis of EINSTEIN-Jr. Blood Adv. 2022 Nov 22;6(22):5821-5828. doi: 10.1182/bloodadvances.2022008160.
	35919876	0	Bastas D, Vincelli J, De R, et al. Impact of deep vein thrombosis on adolescent athletes: Navigating an invisible disability. Res Pract Thromb Haemost. 2022 Jul 29;6(5):e12779. doi: 10.1002/rth2.12779. eCollection 2022 Jul.
	35909257	0	Mitchell LG, Roshammar D, Huang F, et al. Anticoagulant Effects of Dabigatran on Coagulation Laboratory Parameters in Pediatric Patients: Combined Data from Five Pediatric Clinical Trials. Thromb Haemost. 2022 Sep;122(9):1573-1583. doi: 10.1055/s-0042-1744542. Epub 2022 Jul 31.
	35748322	0	Woods GM, Raffini L, Brandao LR, et al. Practical considerations and consensus opinion for children's hospital-based inpatient hemostasis and thrombosis (HAT) consultative services: Communication from the ISTH SSC Subcommittee on Pediatric/Neonatal Thrombosis and Hemostasis. J Thromb Haemost. 2022 Sep;20(9):2151-2158. doi: 10.1111/jth.15798. Epub 2022 Jul 18.
	35570328	0	Betensky M, Kulkarni K, Rizzi M, et al. Recommendations for standardized definitions, clinical assessment, and future research in pediatric clinically unsuspected venous thromboembolism: Communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis. J Thromb Haemost. 2022 Jul;20(7):1729-1734. doi: 10.1111/jth.15731. Epub 2022 May 15.
	35570324	0	Minford A, Brandao LR, Othman M, et al. Diagnosis and management of severe congenital protein C deficiency (SCPCD): Communication from the SSC of the ISTH. J Thromb Haemost. 2022 Jul;20(7):1735-1743. doi: 10.1111/jth.15732. Epub 2022 May 15.
	35503347	0	Goldenberg NA, Brandao LR, Male C. Anticoagulant Therapy for 6 Weeks vs 3 Months and Recurrence and Bleeding in Patients Younger Than 21 Years With Provoked Venous Thromboembolism-Reply. JAMA. 2022 May 3;327(17):1709-1710. doi: 10.1001/jama.2022.3729.
	35389524	0	Avila ML, Amiri N, Zavareh ZT, et al. Characterization of recurrent thrombosis in pediatric antiphospholipid syndrome. Am J Hematol. 2022 Jul;97(7):E268-E270. doi: 10.1002/ajh.26565. Epub 2022 Apr 16.
	34970670	0	Faustino EVS, Karam O, Parker RI, et al. Coagulation Dysfunction Criteria in Critically Ill Children: The PODIUM Consensus Conference. Pediatrics. 2022 Jan 1;149(1 Suppl 1):S79-S83. doi: 10.1542/peds.2021-052888L.
	34687696	0	Male C, Monagle P, Albisetti M, et al. Direct Oral Anticoagulants: Overcoming the Challenges of Managing Venous Thromboembolism in Children. J Pediatr. 2022 Jan;240:14-23. doi: 10.1016/j.jpeds.2021.09.025. Epub 2021 Oct 21.
	34474480	0	Avila L, Amiri N, De R, et al. Characteristics of upper- and lower-extremity deep vein thrombosis and predictors of postthrombotic syndrome in children. Blood Adv. 2021 Oct 12;5(19):3737-3747. doi: 10.1182/bloodadvances.2021004727.
	34418289	0	Avila L, Amiri N, De R, et al. Compression garments for the management of pediatric post-thrombotic syndrome: A prospective longitudinal study. J Thromb Haemost. 2021 Dec;19(12):3073-3079. doi: 10.1111/jth.15507. Epub 2021 Aug 30.
	33971679	0	Branstetter JW, Kiskaddon AL, King MA, et al. Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants in Pediatric Venous Thromboembolism Treatment and Thromboprophylaxis: A Systematic Review of the Literature. Semin Thromb Hemost. 2021 Sep;47(6):643-653. doi: 10.1055/s-0041-1725944. Epub 2021 May 10.
	33930198	0	Avila L, Amiri N, Pullenayegum E, et al. Diagnostic value of D-dimers for limb deep vein thrombosis in children: A prospective study. Am J Hematol. 2021 Aug 1;96(8):954-960. doi: 10.1002/ajh.26212. Epub 2021 May 15.
	33848369	0	Pelland-Marcotte MC, Kulkarni K, Athale UH, et al. Thrombosis is associated with worse survival in children with acute lymphoblastic leukemia: A report from CYP-C. Am J Hematol. 2021 Jul 1;96(7):796-804. doi: 10.1002/ajh.26193. Epub 2021 May 10.
	33706398	0	Smith J, Thornhill D, Goldenberg NA, et al. Validation of Outcome Instruments for Pediatric Postthrombotic Syndrome: Introducing the Peds-VEINES-QOL, a New Health-Related Quality of Life Instrument. Thromb Haemost. 2021 Oct;121(10):1367-1375. doi: 10.1055/s-0041-1725199. Epub 2021 Mar 11.
	33651481	0	Avila L, Cullinan N, White M, et al. Pediatric May-Thurner Syndrome-Systematic review and individual patient data meta-analysis. J Thromb Haemost. 2021 May;19(5):1283-1293. doi: 10.1111/jth.15284. Epub 2021 Apr 1.
	33636042	0	Roshammar D, Huang F, Albisetti M, et al. Pharmacokinetic modeling and simulation support for age- and weight-adjusted dosing of dabigatran etexilate in children with venous thromboembolism. J Thromb Haemost. 2021 May;19(5):1259-1270. doi: 10.1111/jth.15277. Epub 2021 Mar 26.
	33616995	0	Schmidt ML, Wendel D, Horslen SP, et al. Secondary Anticoagulation Prophylaxis for Catheter-Related Thrombosis in Pediatric Intestinal Failure: Comparison of Short- Vs Long-Term Treatment Protocols. JPEN J Parenter Enteral Nutr. 2021 Sep;45(7):1432-1440. doi: 10.1002/jpen.2055. Epub 2021 Jan 7.
	33290737	0	Halton J, Brandao LR, Luciani M, et al. Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b/3, non-inferiority trial. Lancet Haematol. 2021 Jan;8(1):e22-e33. doi: 10.1016/S2352-3026(20)30368-9. Epub 2020 Dec 5.
	33186402	0	Campos LR, Petroli M, Sztajnbok FR, et al. Risk factors for the development of hospital-acquired pediatric venous thromboembolism-Dealing with potentially causal and confounding risk factors using a directed acyclic graph (DAG) analysis. PLoS One. 2020 Nov 13;15(11):e0242311. doi: 10.1371/journal.pone.0242311. eCollection 2020.
	32951663	0	Sun LR, Linds A, Sharma M, et al. Cancer and Tumor-Associated Childhood Stroke: Results From the International Pediatric Stroke Study. Pediatr Neurol. 2020 Oct;111:59-65. doi: 10.1016/j.pediatrneurol.2020.06.002. Epub 2020 Jun 10.
	32697954	0	Low T, Jegatheeswaran A, Devlin PJ, et al. Bleeding risk associated with combination thromboprophylaxis therapy is low for patients with coronary artery aneurysms after Kawasaki disease. Int J Cardiol. 2020 Dec 15;321:6-11. doi: 10.1016/j.ijcard.2020.07.022. Epub 2020 Jul 19.
	32640269	0	Avila L, Amiri N, Yenson P, et al. Heparin-Induced Thrombocytopenia in a Pediatric Population: Implications for Clinical Probability Scores and Testing. J Pediatr. 2020 Nov;226:167-172.e2. doi: 10.1016/j.jpeds.2020.06.081. Epub 2020 Jul 5.
	32614496	0	Engel ER, Nguyen ATH, Amankwah EK, et al. Predictors of postthrombotic syndrome in pediatric thrombosis: A systematic review and meta-analysis of the literature. J Thromb Haemost. 2020 Oct;18(10):2601-2612. doi: 10.1111/jth.14984. Epub 2020 Aug 26.
	32557627	0	Pelland-Marcotte MC, Amiri N, Avila ML, et al. Low molecular weight heparin for prevention of central venous catheter-related thrombosis in children. Cochrane Database Syst Rev. 2020 Jun 18;6(6):CD005982. doi: 10.1002/14651858.CD005982.pub3.
	32065663	0	Avila ML, Shah PS, Brandao LR. Different unfractionated heparin doses for preventing arterial thrombosis in children undergoing cardiac catheterization. Cochrane Database Syst Rev. 2020 Feb 17;2(2):CD010196. doi: 10.1002/14651858.CD010196.pub3.
	31805182	0	Brandao LR, Albisetti M, Halton J, et al. Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children. Blood. 2020 Feb 13;135(7):491-504. doi: 10.1182/blood.2019000998.
	31624784	0	Avila ML, Feldman BM, Pullenayegum E, et al. Post-thrombotic syndrome in children: Measurement properties of CAPTSure, a new diagnostic tool. Res Pract Thromb Haemost. 2019 Aug 28;3(4):652-657. doi: 10.1002/rth2.12251. eCollection 2019 Oct.
	31600808	0	Pelland-Marcotte MC, Tole S, Pechlivanoglou P, et al. Effectiveness and Safety of Primary Thromboprophylaxis in Children with Cancer: A Systematic Review of the Literature and Network Meta-Analysis. Thromb Haemost. 2019 Dec;119(12):2034-2042. doi: 10.1055/s-0039-1697027. Epub 2019 Oct 10.
	31442694	0	Avila ML, Montoya M, Lumia C, et al. Compression stockings to prevent post-thrombotic syndrome in adults, a Bayesian meta-analysis. Thromb Res. 2019 Oct;182:20-26. doi: 10.1016/j.thromres.2019.08.005. Epub 2019 Aug 12.
	31221393	0	Tole S, Price V, Pope E, et al. Abnormal hemostasis in children with vascular anomalies, part I: Thrombocytopenias among different vascular anomalies. Thromb Res. 2020 Dec;196:626-634. doi: 10.1016/j.thromres.2019.06.004. Epub 2019 Jun 13.
	30928485	0	Gnannt R, Chamlati R, Waespe N, et al. Clinical Impact of Chronic Venous Changes Induced by Central Lines in Children: A Cohort with Abnormal Venograms. J Vasc Interv Radiol. 2019 May;30(5):715-723. doi: 10.1016/j.jvir.2018.08.034. Epub 2019 Mar 27.
	30772417	0	Pelland-Marcotte MC, Tucker C, Klaassen A, et al. Outcomes and risk factors of massive and submassive pulmonary embolism in children: a retrospective cohort study. Lancet Haematol. 2019 Mar;6(3):e144-e153. doi: 10.1016/S2352-3026(18)30224-2. Epub 2019 Feb 13.
	30534007	0	Kubitza D, Willmann S, Becka M, et al. Exploratory evaluation of pharmacodynamics, pharmacokinetics and safety of rivaroxaban in children and adolescents: an EINSTEIN-Jr phase I study. Thromb J. 2018 Dec 4;16:31. doi: 10.1186/s12959-018-0186-0. eCollection 2018.
	30528575	0	Manlhiot C, McCrindle BW, Williams S, et al. Characterization of Post-Thrombotic Syndrome in Children with Cardiac Disease. J Pediatr. 2019 Apr;207:42-48. doi: 10.1016/j.jpeds.2018.10.064. Epub 2018 Dec 7.
	30482766	0	Monagle P, Cuello CA, Augustine C, et al. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv. 2018 Nov 27;2(22):3292-3316. doi: 10.1182/bloodadvances.2018024786.
	30046764	0	Avila ML, Feldman BM, Williams S, et al. Assessment of limb edema in pediatric post-thrombotic syndrome. Res Pract Thromb Haemost. 2018 Apr 17;2(3):591-595. doi: 10.1002/rth2.12082. eCollection 2018 Jul.
	30046763	0	Luciani M, Albisetti M, Biss B, et al. Phase 3, single-arm, multicenter study of dabigatran etexilate for secondary prevention of venous thromboembolism in children: Rationale and design. Res Pract Thromb Haemost. 2018 Apr 24;2(3):580-590. doi: 10.1002/rth2.12093. eCollection 2018 Jul.
	30046738	0	Albisetti M, Biss B, Bomgaars L, et al. Design and rationale for the DIVERSITY study: An open-label, randomized study of dabigatran etexilate for pediatric venous thromboembolism. Res Pract Thromb Haemost. 2018 Mar 25;2(2):347-356. doi: 10.1002/rth2.12086. eCollection 2018 Apr.
	30046736	0	Avila ML, Stinson J, Lumia C, et al. Characteristics of pain, other symptoms and function in pediatric post-thrombotic syndrome. Res Pract Thromb Haemost. 2018 Apr 15;2(2):334-338. doi: 10.1002/rth2.12099. eCollection 2018 Apr.
	30046708	0	Albisetti M, Schlosser A, Brueckmann M, et al. Rationale and design of a phase III safety trial of idarucizumab in children receiving dabigatran etexilate for venous thromboembolism. Res Pract Thromb Haemost. 2017 Nov 17;2(1):69-76. doi: 10.1002/rth2.12053. eCollection 2018 Jan.
	29724900	0	Avila ML, Amiri N, Stanojevic S, et al. Can thrombophilia predict recurrent catheter-related deep vein thrombosis in children? Blood. 2018 Jun 14;131(24):2712-2719. doi: 10.1182/blood-2017-10-811216. Epub 2018 May 3.
	29487965	0	Gnannt R, Waespe N, Temple M, et al. Increased risk of symptomatic upper-extremity venous thrombosis with multiple peripherally inserted central catheter insertions in pediatric patients. Pediatr Radiol. 2018 Jul;48(7):1013-1020. doi: 10.1007/s00247-018-4096-x. Epub 2018 Feb 27.
	29202215	0	Halton JML, Picard AC, Harper R, et al. Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Dabigatran Etexilate Oral Liquid Formulation in Infants with Venous Thromboembolism. Thromb Haemost. 2017 Nov;117(11):2168-2175. doi: 10.1160/TH17-06-0429. Epub 2017 Nov 30.
	29178990	0	Nuytemans K, Ortel TL, Gomez L, et al. Variants in chondroitin sulfate metabolism genes in thrombotic storm. Thromb Res. 2018 Jan;161:43-51. doi: 10.1016/j.thromres.2017.11.016. Epub 2017 Nov 21.
	29126655	0	Thom K, Hanslik A, Russell JL, et al. Incidence of infective endocarditis and its thromboembolic complications in a pediatric population over 30years. Int J Cardiol. 2018 Feb 1;252:74-79. doi: 10.1016/j.ijcard.2017.10.085. Epub 2017 Nov 7.
	28674685	0	Silvey M, Brandao LR. Risk Factors, Prophylaxis, and Treatment of Venous Thromboembolism in Congenital Heart Disease Patients. Front Pediatr. 2017 Jun 19;5:146. doi: 10.3389/fped.2017.00146. eCollection 2017.
	27957798	0	Stammers D, Connolly B, Brandao LR, et al. Evaluation of the need for chest X-rays in the management of asymptomatic, intraluminal vascular access device occlusion in childhood cancer. Pediatr Blood Cancer. 2017 Jul;64(7). doi: 10.1002/pbc.26378. Epub 2016 Dec 13.
	27709837	0	Avila ML, Brandao LR, Williams S, et al. Development of CAPTSure(TM) - a new index for the assessment of pediatric postthrombotic syndrome. J Thromb Haemost. 2016 Dec;14(12):2376-2385. doi: 10.1111/jth.13530. Epub 2016 Nov 23.
	27474755	0	Avila ML, Pullenayegum E, Williams S, et al. Postthrombotic syndrome and other outcomes of lower extremity deep vein thrombosis in children. Blood. 2016 Oct 6;128(14):1862-1869. doi: 10.1182/blood-2016-03-704585. Epub 2016 Jul 29.
	27404004	0	Avila ML, Feldman BM, Williams S, et al. Collateral circulation in pediatric post-thrombotic syndrome. Thromb Res. 2016 Aug;144:210-2. doi: 10.1016/j.thromres.2016.07.002. Epub 2016 Jul 4.
	27393923	0	Avila ML, Brandao LR, Williams S, et al. Pediatric post-thrombotic syndrome in children: Toward the development of a new diagnostic and evaluative measurement tool. Thromb Res. 2016 Aug;144:184-91. doi: 10.1016/j.thromres.2016.06.035. Epub 2016 Jul 1.
	27334984	0	Takeuchi M, Kobayashi T, Brandao LR, et al. Effect of CYP2C9, VKORC1, and CYP4F2 polymorphisms on warfarin maintenance dose in children aged less than 18 years: a protocol for systematic review and meta-analysis. Syst Rev. 2016 Jun 23;5(1):105. doi: 10.1186/s13643-016-0280-y.
	27318248	0	Montoya MI, Avila ML, Vincelli J, et al. Understanding the barriers in compliance to elastic compression garments in the treatment of pediatric post-thrombotic syndrome: A qualitative study. Thromb Res. 2016 Aug;144:113-5. doi: 10.1016/j.thromres.2016.06.011. Epub 2016 Jun 14.
	26589345	0	Manlhiot C, Brandao LR, Schwartz SM, et al. Management and Outcomes of Patients with Occlusive Thrombosis after Pediatric Cardiac Surgery. J Pediatr. 2016 Feb;169:146-53. doi: 10.1016/j.jpeds.2015.10.046. Epub 2015 Nov 14.
	26572757	0	Avila ML, Pullenayegum E, Williams S, et al. Timing of low bone mineral density and predictors of bone mineral density trajectory in children on long-term warfarin: a longitudinal study. Osteoporos Int. 2016 Apr;27(4):1547-1557. doi: 10.1007/s00198-015-3411-8. Epub 2015 Nov 16.
	26553458	0	Manlhiot C, Gruenwald CE, Holtby HM, et al. Challenges with heparin-based anticoagulation during cardiopulmonary bypass in children: Impact of low antithrombin activity. J Thorac Cardiovasc Surg. 2016 Feb;151(2):444-50. doi: 10.1016/j.jtcvs.2015.10.003. Epub 2015 Oct 9.
	25963179	0	Sampat HN, Brandao LR, Tamburro RF, et al. HIT or Miss: The Sequential Diagnostic Approach to Heparin-Induced Thrombocytopenia Illustrated in a Child With Acute Post-Streptococcal Glomerulonephritis. Clin Pediatr (Phila). 2016 Mar;55(3):294-7. doi: 10.1177/0009922815586055. Epub 2015 May 11.
	25875618	0	Avila ML, Ward LC, Feldman BM, et al. Normal values for segmental bioimpedance spectroscopy in pediatric patients. PLoS One. 2015 Apr 13;10(4):e0126268. doi: 10.1371/journal.pone.0126268. eCollection 2015.